Objective: To introduce a novel technique for intelligently monitoring and controlling renal pelvic pressure (RPP) in minimally invasive percutaneous nephrolithotomy (MPCNL) and to investigate its reliability and stability. Materials and Methods: A total of 63 kidney stone patients (41 males and 22 females) were enrolled in the study. The average stone size was 3.7 ± 1.1 cm. The average age was 41.6 ± 15.6 years old. All patients underwent MPCNL under combined spinal and epidural anesthesia in prone position. A ureteral catheter connected to an invasive blood pressure monitor was retrogradely placed to measure renal pelvic outlet pressure. The MPCNL was performed with the aid of the patented device, including an irrigation and suctioning platform and a pressure-measuring suctioning sheath. On the platform, the RPP control value was set at –5 mm Hg, and the RPP warning value was set at 20 mm Hg. RPP was measured during the irrigation and suctioning period (ISP), and therapeutic period (TP) when the infusion flow was set at 300, 400, and 500 mL/min, respectively, for 5 min. Results: Sixty-three patients successfully underwent the procedure without serious complications. The mean operative time was 67 min (range 31–127 min). Three patients had residual stones >2 mm in size. No statistical significance was observed between the renal pelvic outlet pressure, platform RPP values, and RPP control values for the 300, 400, and 500 mL/min groups during the ISP and TP (p > 0.05). Conclusion: The patented devices including the platform and the sheath can reliably and stably monitor and control RPP in real time and within a safe range during MPCNL.

Keywords:
Renal pelvic pressure, Pressure feedback, Percutaneous nephrolithotomy
1.
Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU Guidelines on Interventional Treatment for Urolithiasis.
Eur Urol
. 2016 Mar;69(3):475–82.
2.
Troxel SA, Low RK. Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever.
J Urol
. 2002 Oct;168(4 Pt 1):1348–51.
3.
Zhong W, Zeng G, Wu K, Li X, Chen W, Yang H. Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever?
J Endourol
. 2008 Sep;22(9):2147–51.
4.
Omar M, Noble M, Sivalingam S, El Mahdy A, Gamal A, Farag M, et al. Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy: A Randomized Single-Blind Clinical Trial Evaluating the Impact of Irrigation Pressure.
J Urol
. 2016 Jul;196(1):109–14.
5.
Tepeler A, Akman T, Silay MS, Akcay M, Ersoz C, Kalkan S, et al. Comparison of intrarenal pelvic pressure during micro-percutaneous nephrolithotomy and conventional percutaneous nephrolithotomy.
Urolithiasis
. 2014 Jun;42(3):275–9.
6.
Alsyouf M, Abourbih S, West B, Hodgson H, Baldwin DD. Elevated Renal Pelvic Pressures during Percutaneous Nephrolithotomy Risk Higher Postoperative Pain and Longer Hospital Stay.
J Urol
. 2018 Jan;199(1):193–9.
7.
Wollin DA, Carlos EC, Tom WR, Simmons WN, Preminger GM, Lipkin ME. Effect of Laser Settings and Irrigation Rates on Ureteral Temperature During Holmium Laser Lithotripsy, an In Vitro Model.
J Endourol
. 2018 Jan;32(1):59–63.
8.
Aldoukhi AH, Ghani KR, Hall TL, Roberts WW. Thermal Response to High-Power Holmium Laser Lithotripsy.
J Endourol
. 2017 Dec;31(12):1308–12.
9.
Abourbih S, Alsyouf M, Yeo A, Martin J, Vassantachart JM, Lee M, et al. Renal Pelvic Pressure in Percutaneous Nephrolithotomy: The Effect of Multiple Tracts.
J Endourol
. 2017 Oct;31(10):1079–83.
10.
Wu C, Hua LX, Zhang JZ, Zhou XR, Zhong W, Ni HD. Comparison of renal pelvic pressure and postoperative fever incidence between standard- and mini-tract percutaneous nephrolithotomy.
Kaohsiung J Med Sci
. 2017 Jan;33(1):36–43.
11.
Zhu X, Song L, Xie D, Peng Z, Guo S, Deng X, et al. Animal Experimental Study to Test Application of Intelligent Pressure Control Device in Monitoring and Control of Renal Pelvic Pressure During Flexible Ureteroscopy.
Urology
. 2016 May;91:242.e11–5.
12.
Deng X, Song L, Xie D, Huang J, Zhu L, Su G, et al. Suctioning flexible ureteroscopy with automatic control of renal pelvic pressure: a porcine model.
Int J Clin Exp Med
. 2016;9:6563–8.
13.
Deng X, Song L, Xie D, et al. Suctioning Flexible Ureteroscopy with Automatic Control of Renal Pelvic Pressure.
J Urol
. 2015;195:e782.
14.
Yang Z, Song L, Xie D, Deng X, Zhu L, Fan D, et al. The New Generation Mini-PCNL System - Monitoring and Controlling of Renal Pelvic Pressure by Suctioning Device for Efficient and Safe PCNL in Managing Renal Staghorn Calculi.
Urol Int
. 2016;97(1):61–6.
15.
Zeng G, Mai Z, Zhao Z, Li X, Zhong W, Yuan J, et al. Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years.
Urolithiasis
. 2013 Jun;41(3):225–9.
16.
Loftus CJ, Hinck B, Makovey I, Sivalingam S, Monga M. Mini versus Standard Percutaneous Nephrolithotomy: the impact of sheath size on intra-renal pelvic pressure and infectious complications in a porcine model.
J Endourol
. 2018 Apr;32(4):350–3.
17.
Yang Z, Song L, Xie D, Hu M, Peng Z, Liu T, et al. Comparative study of outcome in treating upper ureteral impacted stones using minimally invasive percutaneous nephrolithotomy with aid of patented system or transurethral ureteroscopy.
Urology
. 2012 Dec;80(6):1192–7.
18.
Song L, Chen Z, Liu T, Zhong J, Qin W, Guo S, et al. The application of a patented system to minimally invasive percutaneous nephrolithotomy.
J Endourol
. 2011 Aug;25(8):1281–6.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.